Back to results
US 6,645,964 B1Granted
Chemical derivatives and their application as antitelomerase agent
AssigneeAventis Pharma S.A.
InventorsPatrick Mailliet, Jean-François Riou, Jean-Louis Mergny, Abdelazize Laoui, François Lavelle, Odile Petitgenet
Life of this patent
Estimating the term…
Abstract
The present invention relates to cancer therapy and to novel anticancer agent having a mechanism of action which is quite specific. It also relates to novel chemical compounds as well as their therapeutic application in humans.
Claims19
Compounds which bind the G-quadruplex structure of the telomers, characterized in that they correspond to the following general formula:
- nitrogen-containing aromatic ring —NR3— distribution agent —NR′3— aromatic ring
- in which
- nitrogen-containing aromatic ring represents:
- a quinoline optionally substituted with at least one group in which Ra and Rb, which are identical or different, represent a short-chain C1-C4 alkyl, alkoxy radical,
- a quinoline possessing a nitrogen atom in quaternary form,
- a benzamidine, or
- a pyridine
- the aromatic ring represents
- a quinoline optionally substituted with at least one group N(Ra) (Rb) in which Ra and Rb, which are identical or different, represent hydrogen, a short-chain C1-C4 alkyl, alkoxy radical,
- a quinoline possessing a nitrogen atom quaternary form,
- a benzamidine,
- a pyridine,
- a phenyl ring optionally substituted at the meta or para position with a halogen group, C1-C4 alkoxy group, cyano group, carbonylamino group optionally substituted with one or more C1-C4 alkyl groups, guanyl groups, C1-C4 alkylthio groups, amino groups, C1-C4 alkylamino groups, C1-C4 dialkylamino groups for each alkyl group, nitro group, alkylene-amino group or alkenyleneamino group, or
- a mono- or bi- or tricyclic hetero-cyclic ring comprising 0 to 2 heteroatoms per ring provided that at least one heteroatom is present in at least one ring optionally substituted with one or more C1-C4 alkyl groups, or with alkylene or alkenylene groups
- R3 and R′3, which are identical or different, represent independently of one another hydrogen or a C1-C4 alkyl radical
- the distribution agent represents:
- a triazine group optionally substituted with an alkyl radical having 1 to 4 carbon atoms, a thio, oxy or amino radical which are themselves optionally substituted with one or more short-chain alkyl chains containing 1 to 4 carbon atoms or a halogen atom
- or one of its salts
- with the proviso that the compound is not (a) benzenecarboximidamide,4-[4-chloro-6-(phenylamino)-1,3,5-triazin-2-yl]amino, or (b) 1,3,5-triazine-2,4,6-triamine,N,N′-bis(4-amino-2-methyl-6-quinolinyl)-trihydrochloride.
16 more elements
Compounds corresponding to the following formula (I):
- in which:
- A represents
- an amino group of formula NR1 R2 in which R1 and R2, which are identical or different, represent hydrogen or a straight or branched alkyl group containing 1 to 4 carbon atoms,
- a group OR1 or SR1 in which R1 has the same meaning as above,
- an alkyl group containing 1 to 4 carbon atoms or a trifluoromethyl group,
- a hydrogen atom, or
- a halogen atom chosen from fluorine, chlorine, bromine or iodine
- R3 and R′3, which are identical or different, represent independently of one another a hydrogen atom or a C1-C4 alkyl group
- Ar1 and Ar2, which are identical or different, represent
- 1. when Art and Ar2 are identical:
- a quinoline motif optionally substituted with at least one group N(Ra)(Rb) in which Ra and Rb, which are identical or different, represent hydrogen, or a short-chain alkyl, alkoxy radical containing 1 to 4 carbon atoms,
- a quinoline possessing a nitrogen atom in quaternary form,
- a benzamidine except in the case where A represents diethylamine, hydrogen or an amine group, or
- a pyridine attached at the 4-position or fused with an aryl or heteroaryl group optionally substituted with a C1-C4 alkyl group
- 2. when Ar1 and Ar2 are different
- Ar1 and Ar2 both represent one of the possibilities mentioned above for Ar1 and Ar2 or
- Ar1 represents one of the above possibilities and Ar2 represents
- a phenyl ring optionally substituted at the meta or para position with a halogen group, C1-C4 alkoxy group, cyano group, carbonylamino group optionally substituted with one or more C1-C4 alkyl groups, guanyl groups, C1-C4 alkylthio groups, amino groups, C1-C4 alkylamino groups, C1-C4 dialkylamino groups for each alkyl group, nitro group, alkyleneamino group, or alkenyleneamino group
- a mono- or bi- or tricyclic hetero-cyclic ring comprising 0 to 2 heteroatoms per ring provided that at least one heteroatom is present in at least one ring optionally substituted with one or more C1-C4 alkyl groups or with alkylene or alkenylene groups
- or one or its salts
- excluding 2-amino-bis-4,6-[(4′-amino-6′-quinaldinyl)amino]triazine dihydrochloride and 2-amino-bis-4,6-(p-amidinoanilino) triazine dihydrochloride;
- and
- with the proviso that the compound is not (a) benzenecarboximidamide,4-[4-chloro-6-(phenylamino)-1,3,5-triazin-2-yl]amino, or (b) 1,3,5-triazine-2,4,6-triamine,N,N′-bis(4-amino-2-methyl-6- quinolinyl)-trihydrochloride.
20 more elements
Dependencies are inferred from the claim text.